IMVT icon

Immunovant

197 hedge funds and large institutions have $1.97B invested in Immunovant in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 82 increasing their positions, 65 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

6% less funds holding

Funds holding: 209197 (-12)

13% less capital invested

Capital invested by funds: $2.27B → $1.97B (-$300M)

29% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 35

Holders
197
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$24.3M
Puts
$23.6M
Net Calls
Net Calls Change

Top Buyers

1 +$74.7M
2 +$63.1M
3 +$42.9M
4
AC
Armistice Capital
New York
+$32.5M
5
PBA
Paradigm Biocapital Advisors
New York
+$14.9M

Top Sellers

1 -$44.7M
2 -$31.7M
3 -$27.4M
4
State Street
State Street
Massachusetts
-$24.4M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$20.4M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$3.15M
77
$3.01M
78
$2.63M
79
$2.61M
80
$2.6M
81
$2.45M
82
$2.42M
83
$2.28M
84
$2.21M
85
$2.11M
86
$1.99M
87
$1.89M
88
$1.89M
89
$1.85M
90
$1.8M
91
$1.72M
92
$1.71M
93
$1.61M
94
$1.56M
95
$1.55M
96
$1.53M
97
$1.5M
98
$1.46M
99
$1.45M
100
$1.43M